Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 484

1.

Risk and predictors of mortality associated with chronic hepatitis B infection.

Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-Hepatitis B Virus Study Group.

Clin Gastroenterol Hepatol. 2007 Aug;5(8):921-31.

PMID:
17678844
2.

Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.

Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, You SL, Iloeje UH, Chen CJ; REVEAL-HBV Study Group.

Gastroenterology. 2010 Aug;139(2):474-82. doi: 10.1053/j.gastro.2010.04.048. Epub 2010 Apr 29.

PMID:
20434450
3.

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.

Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group.

Gastroenterology. 2010 May;138(5):1747-54. doi: 10.1053/j.gastro.2010.01.042. Epub 2010 Jan 28.

PMID:
20114048
4.

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.

PMID:
19535774
5.

Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan.

Fwu CW, Chien YC, Nelson KE, Kirk GD, You SL, Kuo HS, Feinleib M, Chen CJ.

J Infect Dis. 2010 Apr 1;201(7):1016-23. doi: 10.1086/651231.

PMID:
20187745
6.

The long-term course of chronic hepatitis B.

Di Marco V, Lo Iacono O, Cammà C, Vaccaro A, Giunta M, Martorana G, Fuschi P, Almasio PL, Craxì A.

Hepatology. 1999 Jul;30(1):257-64.

PMID:
10385664
7.

Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.

Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu, Yu ML.

Clin Ther. 2006 Dec;28(12):2081-92.

PMID:
17296464
8.

Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

Manno M, Cammà C, Schepis F, Bassi F, Gelmini R, Giannini F, Miselli F, Grottola A, Ferretti I, Vecchi C, De Palma M, Villa E.

Gastroenterology. 2004 Sep;127(3):756-63.

PMID:
15362032
9.

Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study.

Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Lu SN, Chen CJ.

Liver Int. 2010 Mar;30(3):423-9. doi: 10.1111/j.1478-3231.2009.02147.x. Epub 2009 Oct 16.

PMID:
19840258
10.

Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age.

Tai DI, Tsay PK, Chen WT, Chu CM, Liaw YF.

Am J Gastroenterol. 2010 May;105(5):1102-9. doi: 10.1038/ajg.2009.669. Epub 2010 Mar 2.

PMID:
20197760
11.

Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study.

Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA.

Int J Epidemiol. 2005 Feb;34(1):132-7. Epub 2005 Jan 19.

PMID:
15659459
12.

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ.

J Natl Cancer Inst. 2005 Feb 16;97(4):265-72.

PMID:
15713961
13.

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.

Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E; European Concerted Action on Viral Hepatitis (EUROHEP).

Am J Gastroenterol. 2002 Nov;97(11):2886-95.

PMID:
12425564
14.

Mortality of hepatitis B surface antigen-positive blood donors in England and Wales.

Crook PD, Jones ME, Hall AJ.

Int J Epidemiol. 2003 Feb;32(1):118-24.

PMID:
12690022
15.

Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.

Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP.

Clin Gastroenterol Hepatol. 2007 Aug;5(8):938-45, 945.e1-4. Epub 2007 May 16.

PMID:
17509946
16.

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.

Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group.

Gastroenterology. 2006 Mar;130(3):678-86.

PMID:
16530509
17.

Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.

Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, Su J, Hsiao CK, Wang LY, You SL, Lu SN, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL–HBV) Study Group.

Gastroenterology. 2011 Oct;141(4):1240-8, 1248.e1-2. doi: 10.1053/j.gastro.2011.06.036. Epub 2011 Jun 22.

PMID:
21703214
18.

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ.

J Clin Oncol. 2010 May 10;28(14):2437-44. doi: 10.1200/JCO.2009.27.4456. Epub 2010 Apr 5.

PMID:
20368541
19.

Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group.

N Engl J Med. 2002 Jul 18;347(3):168-74.

20.

The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.

Zacharakis G, Koskinas J, Kotsiou S, Tzara F, Vafeiadis N, Papoutselis M, Maltezos E, Sivridis E, Papoutselis K.

J Hepatol. 2008 Dec;49(6):884-91. doi: 10.1016/j.jhep.2008.06.009. Epub 2008 Jul 2. Erratum in: J Hepatol. 2009 May;50(5):1065.

PMID:
18674840

Supplemental Content

Support Center